CLINICAL_TRIALS
trial_result
· 2017-11-28
Clinical Trial Update: Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas [Phase 2]
Summary
A Phase 2 clinical trial evaluating pasireotide long-acting release for gonadotroph adenomas was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pennsylvania | Conditions: Gonadotroph Adenomas | Phase 2 | Status: TERMINATED | Results posted: 2017-11-28